Optune Gio® | FDA-approved glioblastoma (GBM) treatment
Optune Gio is a wearable, portable, FDA-approved glioblastoma (GBM) treatment for adult patients aged 22 years or older. It works by creating Tumor Treating Fields (TTFields), which are electric fields that can slow down or stop GBM cancer division. Learn about Optune Gio.
Optune device, positive outlook let glioblastoma patient live his life
2023年1月2日 · Glioblastoma accounts for about half of all brain tumors in the U.S. The Novocure Optune device has been proven to slow growth of the tumors.
Optune: Uses, Side Effects, Dosages, Precautions - Verywell Health
2023年1月20日 · Optune is a wearable device to treat glioblastoma (GBM) brain cancer with a low-intensity electrical field. Reviewed by a board-certified physician.
Get to know Optune Gio®, a GBM treatment option | Optune Gio®
Optune Gio is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older. If you have newly diagnosed GBM, Optune Gio is used together with a chemotherapy called temozolomide (TMZ) if:
Efficacy of tumour-treating fields therapy in recurrent glioblastoma…
2023年12月12日 · Tumour Treating Fields (TTFields) therapy has emerged as a promising noninvasive approach in the realm of antimitotic treatments, offering a viable avenue for addressing the formidable challenge posed by recurrent Glioblastoma (rGBM), a devastating and often refractory malignant brain tumor.
Treating GBM: Glioblastoma treatment options - Optune Gio®
Optune Gio is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older. Newly diagnosed GBM If you have newly diagnosed GBM, Optune Gio is used together with a chemotherapy called temozolomide (TMZ) if:
The Optune Gio™ System For Treating GBM | Optune Gio™
Optune Gio with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy.
Patients Who Used Optune® More Than 90 Percent of the Time ... - Novocure
2017年11月17日 · Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.
Optune - Treatment Option for Recurrent Glioblastoma
Optune is a portable Tumor Treating Fields (TTFields) delivery system that provides a non invasive anti-cell division therapy that targets dividing cancer cells in the brain. Optune received recent FDA approval for the treatment of recurrent GMB. TTFields are alternative, low-intensity, “wave-like” electric fields.
Tumor Treating Fields for Glioblastoma Treatment: Patient …
2019年1月29日 · The Phase III EF-14 trial in newly diagnosed glioblastoma multiforme (GBM) showed significantly improved progression-free, overall and long-term survival when Optune was used together with maintenance temozolomide (TMZ) compared with TMZ alone.
- 某些结果已被删除